Skip to main content

Advertisement

SpringerLink
Log in

Expression of C-kit and Platelet-Derived Growth Factor Receptors in Ovarian Granulosa Cell Tumors

  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Objective. This study aimed at evaluating the expression of tyrosine kinase receptors c-kit, (platelet-derived growth factor receptor-α (PDGFR-α), and PDGFR- β in ovarian granulosa cell tumors (GCTs). Study design. Primary ovarian GCT specimens were obtained for immunohistochemical staining. The expressions of c-kit, PDGFR-α, and PDGFR-β were analyzed and scored by a semiquantitative (SQ) method. Normal ovarian tissue from the same patients’ specimens served as internal controls. Results. A total of 21 specimens were available for evaluation. C-kit was expressed in only 2 samples, whereas both PDGFR-α and PDGFR-β stained positive in 100% of tumors. PDGFR targets demonstrated strong positive expression in intensity and amount of tissue stained. Normal ovarian tissue demonstrated complete absence of staining for all 3 antibodies evaluated. Conclusions. The data demonstrated significant expression of PDGFR targets of imatinib mesylate in GCTs, whereas normal ovarian tissues had a complete absence of staining. This expression profile provides the rationale to investigate the role of imatinib mesylate in PDGFR-positive GCTs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279:577–580.

    Article  CAS  Google Scholar 

  2. Tsujimura T, Hashimoto K, Kitayama H, et al. Activating mutation in the catalytic domain of c-kit elicits hematopoietic transformation by receptor self-association not at the ligand-induced dimerization site. Blood. 1999;93:1319–1329.

    Article  CAS  Google Scholar 

  3. Morin MJ. From oncogene to drug: development of small molecule tyrosine kinase inhibitors as anti-tumor and antiangiogenic agents. Oncogene. 2000;19:6574–6583.

    Article  CAS  Google Scholar 

  4. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science. 2002;298:1912–1934.

    Article  CAS  Google Scholar 

  5. Verweij J, Judson I, van Oosterom A. STI571: a magic bullet? Eur J Cancer. 2001;37:1816–1819.

    Article  CAS  Google Scholar 

  6. Arber DA, Tamayo R, Weiss LM. Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders. Hum Pathol. 1998;29:498–504.

    Article  CAS  Google Scholar 

  7. Henriksen R, Funa K, Wilander E, Bäckström T, Ridderheim M, Oberg K. Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms. Cancer Res. 1993;53:4550–4554.

    CAS  PubMed  Google Scholar 

  8. Matei D, Graeber TG, Baldwin RL, Karlan BY, Rao J, Chang DD. Gene expression in epithelial ovarian carcinoma. Oncogene. 2002;21:6289–6298.

    Article  CAS  Google Scholar 

  9. Schmandt RE, Broaddus R, Lu KH, et al. Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium. Cancer. 2003;98:758–764.

    Article  CAS  Google Scholar 

  10. Versnel MA, Haarbrink M, Langerak AW, et al. Human ovarian tumors of epithelial origin express PDGF in vitro and in vivo. Cancer Genet Cytogenet. 1994;73:60–64.

    Article  CAS  Google Scholar 

  11. Wilczynski SP, Chen YY, Chen W, Howell SB, Shivley JE, Alberts DS. Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers. Hum Pathol. 2005;36:242–249.

    Article  CAS  Google Scholar 

  12. Manne U, Myers RB, Moron C, et al. Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma. Int J Cancer. 1997;74:346–358.

    Article  CAS  Google Scholar 

  13. Gershenson DM, Morris M, Burke TW, Lavenback C, Matthews CM, Wharton JT. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstet Gynecol. 1996;87:527–531.

    Article  CAS  Google Scholar 

  14. Homesley HD, Bundy BN, Hurteau JA, Roth LM. Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: a Gynecologic Oncology Group study. Gynecol Oncol. 1999;72:131–137.

    Article  CAS  Google Scholar 

  15. Lauszus FF, Petersen AC, Greisen J, Jakobsen A. Granulosa cell tumor of the ovary: a population-based study of 37 women with stage I disease. Gynecol Oncol. 2001;81:456–460.

    Article  CAS  Google Scholar 

  16. Leibl S, Bodo K, Gogg-Kammerer M, et al. Ovarian granulosa cell tumors frequently express EGFR (Her-1), Her-3, and Her-4: an immunohistochemical study. Gynecol Oncol. 2006; 101:18–23.

    Article  CAS  Google Scholar 

  17. Carvalho I, Milanezi F, Martins A, Reis RM, Schmitt F. Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression. Breast Cancer Res. 2005;7:R788–R795.

    Article  CAS  Google Scholar 

  18. Hwang RF, Yokoi K, Bucana CD, et al. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model. Clin Cancer Res. 2003;9:6534–6544.

    CAS  PubMed  Google Scholar 

  19. Basciani S, Brama M, Mariani S, et al. Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity. Cancer Res. 2005;65:1897–1903.

    Article  CAS  Google Scholar 

  20. Beppu K, Jaboine J, Merchant MS, Mackall CL, Thiele CJ. Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression. J Natl Cancer Inst. 2004;96:46–55.

    Article  CAS  Google Scholar 

  21. Kilic T, Alberta JA, Zdunek PR, et al. Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class. Cancer Res. 2000;60:5143–5150.

    CAS  PubMed  Google Scholar 

  22. Krystal GW, Honsawek S, Litz J, Buchdunger E. The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth. Clin Cancer Res. 2000;6:3319–3326.

    CAS  PubMed  Google Scholar 

  23. Merchant MS, Woo CW, Mackall CL, Thiele CJ. Potential use of imatinib in Ewing’s sarcoma: evidence for in vitro and in vivo activity. J Natl Cancer Inst. 2002;94:1673–1679.

    Article  CAS  Google Scholar 

  24. Sjoblom T, Shimizu A, O’Brien KP, et al. Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis. Cancer Res. 2001;61:5778–5783.

    CAS  PubMed  Google Scholar 

  25. Chu S, Alexiadis M, Fuller PJ. Expression, mutational analysis and in vitro response of imatinib mesylate and nilotinib target genes in ovarian granulosa cell tumors. Gynecol Oncol. 2008;108:182–190.

    Article  CAS  Google Scholar 

  26. Tonary AM, Macdonald EA, Faught W, Senterman MK, Venderhyden BC. Lack of expression of c-KIT in ovarian cancers is associated with poor prognosis. Int J Cancer. 2000; 89:242–250.

    Article  CAS  Google Scholar 

  27. Inoue M, Kyo S, Fujita M, Enomoto T, Kondoh G. Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors. Cancer Res. 1994;54:3049–3053.

    CAS  PubMed  Google Scholar 

  28. Parrott JA, Kim G, Skinner MK. Expression and action of kit ligand/stem cell factor in normal human and bovine ovarian surface epithelium and ovarian cancer. Biol Reprod. 2000;62:1600–1609.

    Article  CAS  Google Scholar 

  29. Parrott JA, Mosher R, Kim G, Skinner MK. Autocrine interactions of keratinocyte growth factor, hepatocyte growth factor, and kit-ligand in the regulation of normal ovarian surface epithelial cells. Endocrinology. 2000;141:2532–2539.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, University of South Alabama-Mitchell Cancer Institute, 1 Mobile Infirmary Circle, 1st Floor, Mobile, Alabama, 36607, USA

    Rodney P. Rocconi MD (Abraham A. Mitchell Cancer Research Scholar)

  2. Division of Gynecologic Oncology, University of Alabama, Birmingham, Alabama, USA

    Kellie S. Matthews MD, Kristopher J. Kimball MD & Mack N. Barnes MD

  3. Division of Surgical pathology, University of Alabama, Birmingham, Alabama, USA

    Michael G. Conner MD & Allyson C. Baker MD

Authors
  1. Rodney P. Rocconi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kellie S. Matthews MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kristopher J. Kimball MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael G. Conner MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Allyson C. Baker MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mack N. Barnes MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rodney P. Rocconi MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rocconi, R.P., Matthews, K.S., Kimball, K.J. et al. Expression of C-kit and Platelet-Derived Growth Factor Receptors in Ovarian Granulosa Cell Tumors. Reprod. Sci. 15, 673–677 (2008). https://doi.org/10.1177/1933719108317584

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719108317584

Key words

Search

Navigation